Neutrophilic myeloid‐derived suppressor cells in cord blood modulate innate and adaptive immune responses. (8th September 2013)

• Record Type: Journal Article
• Authors: Rieber, N.; Gille, C.; Köstlin, N.; Schäfer, I.; Spring, B.; Ost, M.; Spieles, H.; Kugel, H. A.; Pfeiffer, M.; Heininger, V.; Alkhaled, M.; Hector, A.; Mays, L.; Kormann, M.; Zundel, S.; Fuchs, J.; Handgretinger, R.; Poets, C. F.; Hartl, D.
• Is Part Of: Clinical and experimental immunology. Volume 174:Number 1(2013:Oct.)
• Page Start: 45
• Page End: 52
• Publication Date: 2013-09-08
• Subjects: Immunopathology -- Periodicals; 616.079
• DOI: 10.1111/cei.12143
• Languages: English
• ISSNs: 0009-9104

Abstract

<abstract abstract-type="main"> <title>Summary</title> <p>Neonates show an impaired anti‐microbial host defence, but the underlying immune mechanisms are not understood fully. Myeloid‐derived suppressor cells (MDSCs) represent an innate immune cell subset characterized by their capacity to suppress T cell immunity. In this study we demonstrate that a distinct MDSC subset with a neutrophilic/granulocytic phenotype (Gr‐MDSCs) is highly increased in cord blood compared to peripheral blood of children and adults. Functionally, cord blood isolated Gr‐MDSCs suppressed T cell proliferation efficiently as well as T helper type 1 (Th1), Th2 and Th17 cytokine secretion. Beyond T cells, cord blood Gr‐MDSCs controlled natural killer (NK) cell cytotoxicity in a cell contact‐dependent manner. These studies establish neutrophilic Gr‐MDSCs as a novel immunosuppressive cell subset that controls innate (NK) and adaptive (T cell) immune responses in neonates. Increased MDSC activity in cord blood might serve as key fetomaternal immunosuppressive mechanism impairing neonatal host defence. Gr‐MDSCs in cord blood might therefore represent a therapeutic target in neonatal infections.</p> </abstract>